These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 7790373)

  • 1. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
    J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
    Nishitoh H; Ichijo H; Kimura M; Matsumoto T; Makishima F; Yamaguchi A; Yamashita H; Enomoto S; Miyazono K
    J Biol Chem; 1996 Aug; 271(35):21345-52. PubMed ID: 8702914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
    Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P
    J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.
    Yonemori K; Imamura T; Ishidou Y; Okano T; Matsunaga S; Yoshida H; Kato M; Sampath TK; Miyazono K; ten Dijke P; Sakou T
    Am J Pathol; 1997 Apr; 150(4):1335-47. PubMed ID: 9094990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
    Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
    J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of receptors for bone morphogenetic proteins].
    Nishitoh H
    Kokubyo Gakkai Zasshi; 1997 Mar; 64(1):24-37. PubMed ID: 9125848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
    Yeh LC; Betchel KP; Lee JC
    J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
    Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
    Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
    ten Dijke P; Yamashita H; Sampath TK; Reddi AH; Estevez M; Riddle DL; Ichijo H; Heldin CH; Miyazono K
    J Biol Chem; 1994 Jun; 269(25):16985-8. PubMed ID: 8006002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
    Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction?
    Schulte-Merker S; Smith JC; Dale L
    EMBO J; 1994 Aug; 13(15):3533-41. PubMed ID: 8062830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell survival effect of activin against heat shock stress on OVCAR3.
    Fukuda J; Ito I; Tanaka T; Leung PC
    Life Sci; 1998; 63(25):2209-20. PubMed ID: 9870706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments.
    Haaijman A; Burger EH; Goei SW; Nelles L; ten Dijke P; Huylebroeck D; Bronckers AL
    Growth Factors; 2000; 17(3):177-92. PubMed ID: 10705576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of activin subunits, activin receptors and follistatin genes in bovine oocytes and preimplantation embryos.
    Yoshioka K; Takata M; Taniguchi T; Yamanaka H; Sekikawa K
    Reprod Fertil Dev; 1998; 10(3):293-8. PubMed ID: 11596877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation.
    Liu H; Zhang R; Chen D; Oyajobi BO; Zhao M
    J Cell Physiol; 2012 Mar; 227(3):952-63. PubMed ID: 21503889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
    Kitamura K; Aota Si; Sakamoto R; Yoshikawa SI; Okazaki K
    Blood; 2000 Jun; 95(11):3371-9. PubMed ID: 10828018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.